Guggenheim Capital’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$720K Sell
10,947
-357
-3% -$18.6K 0.01% 1093
2025
Q4
$478K Sell
11,304
-2,570
-19% -$105K ﹤0.01% 1306
2025
Q3
$584K Buy
13,874
+715
+5% +$35.6K ﹤0.01% 1119
2025
Q2
$728K Sell
13,159
-318
-2% -$15.8K 0.01% 1010
2025
Q1
$765K Sell
13,477
-5,335
-28% -$333K 0.01% 995
2024
Q4
$1.3M Sell
18,812
-15,791
-46% -$1.52M 0.01% 801
2024
Q3
$4.7M Buy
34,603
+4,507
+15% +$592K 0.03% 552
2024
Q2
$4.06M Buy
30,096
+1,734
+6% +$265K 0.03% 581
2024
Q1
$4.87M Sell
28,362
-2,464
-8% -$375K 0.03% 567
2023
Q4
$4.79M Buy
30,826
+5,166
+20% +$674K 0.04% 543
2023
Q3
$3.22M Sell
25,660
-14,245
-36% -$1.75M 0.03% 642
2023
Q2
$4.62M Sell
39,905
-2,475
-6% -$268K 0.04% 550
2023
Q1
$4.61M Sell
42,380
-11,312
-21% -$1.31M 0.04% 546
2022
Q4
$5.49M Buy
53,692
+4,749
+10% +$471K 0.05% 485
2022
Q3
$4.42M Sell
48,943
-8,865
-15% -$974K 0.04% 551
2022
Q2
$6.8M Sell
57,808
-8,785
-13% -$1.26M 0.05% 427
2022
Q1
$9.51M Sell
66,593
-16,774
-20% -$2.56M 0.06% 410
2021
Q4
$14M Buy
83,367
+47,364
+132% +$7.71M 0.07% 303
2021
Q3
$5.42M Sell
36,003
-12,123
-25% -$1.87M 0.03% 628
2021
Q2
$7.3M Buy
48,126
+11,559
+32% +$1.84M 0.04% 515
2021
Q1
$5.48M Buy
36,567
+7,865
+27% +$1.08M 0.04% 590
2020
Q4
$3.73M Buy
28,702
+821
+3% +$102K 0.02% 713
2020
Q3
$3M Buy
27,881
+682
+3% +$68.1K 0.02% 726
2020
Q2
$2.35M Buy
27,199
+5,085
+23% +$424K 0.02% 819
2020
Q1
$1.62M Sell
22,114
-13,874
-39% -$1.37M 0.02% 879
2019
Q4
$4.43M Buy
35,988
+19,337
+116% +$2.38M 0.03% 684
2019
Q3
$2.04M Sell
16,651
-889
-5% -$100K 0.02% 1007
2019
Q2
$1.89M Sell
17,540
-68,635
-80% -$7.11M 0.02% 1079
2019
Q1
$8.5M Sell
86,175
-18,827
-18% -$1.85M 0.07% 355
2018
Q4
$9.45M Buy
105,002
+47,191
+82% +$4.63M 0.08% 282
2018
Q3
$6.59M Buy
57,811
+25,439
+79% +$2.92M 0.04% 561
2018
Q2
$3.6M Sell
32,372
-15,854
-33% -$1.75M 0.02% 903
2018
Q1
$4.83M Buy
48,226
+28,078
+139% +$2.96M 0.01% 1036
2017
Q4
$2.16M Sell
20,148
-30,179
-60% -$3.21M 0.01% 1614
2017
Q3
$5.25M Sell
50,327
-365
-0.7% -$35.9K 0.01% 1036
2017
Q2
$4.81M Buy
50,692
+11,723
+30% +$1.04M 0.01% 1039
2017
Q1
$3.5M Sell
38,969
-5,595
-13% -$489K 0.01% 1241
2016
Q4
$3.51M Sell
44,564
-10,177
-19% -$765K 0.01% 1246
2016
Q3
$3.64M Buy
54,741
+7,075
+15% +$463K 0.01% 1208
2016
Q2
$3.12M Buy
47,666
+30,992
+186% +$2.15M 0.01% 1274
2016
Q1
$1.09M Buy
16,674
+563
+3% +$34.9K ﹤0.01% 1992
2015
Q4
$1.08M Buy
16,111
+2,948
+22% +$200K ﹤0.01% 2065
2015
Q3
$779K Sell
13,163
-33,472
-72% -$2.12M ﹤0.01% 2239
2015
Q2
$3.35M Sell
46,635
-2,896
-6% -$193K 0.01% 1383
2015
Q1
$2.77M Buy
49,531
+999
+2% +$56.5K 0.01% 1514
2014
Q4
$2.91M Buy
48,532
+31,670
+188% +$1.85M 0.01% 1460
2014
Q3
$987K Sell
16,862
-29,980
-64% -$1.85M ﹤0.01% 2224
2014
Q2
$3.01M Sell
46,842
-27,964
-37% -$1.7M 0.01% 1491
2014
Q1
$4.15M Buy
74,806
+24,256
+48% +$1.29M 0.01% 1230
2013
Q4
$2.8M Buy
50,550
+8,974
+22% +$497K 0.01% 1491
2013
Q3
$2.19M Buy
41,576
+25,013
+151% +$1.23M 0.01% 1556
2013
Q2
$742K Buy
+16,563
New +$779K ﹤0.01% 2223

Other funds holding CE

Guggenheim Capital's CE Position: Q1 2026 in Review

Guggenheim Capital reduced its Celanese (CE) stake by 3.2% in Q1 2026, selling an estimated $18.6K and leaving 10,947 shares worth $720K. The position accounts for 0.01% of the portfolio, ranked #1093.

Guggenheim Capital first reported a position in CE in Q2 2013 and has held it in 52 quarters since. The position peaked at $14M in Q4 2021. 471 funds tracked by Wall St. Rank hold CE as of Q1 2026.

  • Guggenheim Capital held 10,947 shares of Celanese worth $720K as of Q1 2026.
  • Guggenheim Capital sold 357 Celanese shares in Q1 2026, an estimated $18.6K.
  • Celanese made up 0.01% of Guggenheim Capital's portfolio in Q1 2026, its #1093 holding.
  • Guggenheim Capital first reported a position in Celanese in Q2 2013 and has held it in 52 quarters since.
  • Guggenheim Capital's Celanese position peaked at $14M in Q4 2021.
  • 471 funds tracked by Wall St. Rank held Celanese as of Q1 2026.

Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.